首页> 外国专利> Use of a human rhinovirus receptor preparation for the manufacture of medicaments for the treatment of rhinovirus infections

Use of a human rhinovirus receptor preparation for the manufacture of medicaments for the treatment of rhinovirus infections

机译:人鼻病毒受体制剂在制备用于治疗鼻病毒感染的药物中的用途

摘要

A water soluble human rhinovirus (HRV) major receptor preparation comprising detergent-complexed glycoprotein isolated from animal cells, preferably mammalian cells, that express the HRV major receptor and which exhibits the ability to bind to HRV capsids to substantially reduce infectivity of the virus. The purified, water soluble receptor is obtained by extracting cells expressing the receptor with detergent and isolating the solubilized detergent-glycoprotein complexes by binding to monoclonal antibody selective for the HRV receptor protein.
机译:一种水溶性人鼻病毒(HRV)主要受体制剂,其包含从表达HRV主要受体的动物细胞,优选哺乳动物细胞中分离的去污剂复合糖蛋白,其表现出结合HRV衣壳的能力,从而实质上降低了病毒的感染性。通过用去污剂提取表达该受体的细胞,并通过与对HRV受体蛋白具有选择性的单克隆抗体结合,分离出可溶解的去污剂-糖蛋白复合物,从而获得纯化的水溶性受体。

著录项

  • 公开/公告号IL91454A

    专利类型

  • 公开/公告日1995-08-31

    原文格式PDF

  • 申请/专利权人 MOLECULAR THERAPEUTICS INC.;

    申请/专利号IL19890091454

  • 发明设计人

    申请日1989-08-28

  • 分类号A61K38/17;

  • 国家 IL

  • 入库时间 2022-08-22 04:19:12

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号